Related references
Note: Only part of the references are listed.Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Barnaby Edward Young et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Dynamic, Helminth-Induced Immune Modulation Influences the Outcome of Acute and Chronic Hepatitis B Virus Infection
Eva Loffredo-Verde et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
Xiao-Wei Xu et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Clinical progression of patients with COVID-19 in Shanghai, China
Jun Chen et al.
JOURNAL OF INFECTION (2020)
Hepatitis B infection in the general population of China: a systematic review and meta-analysis
Huai Wang et al.
BMC INFECTIOUS DISEASES (2019)
Prevalence of Hepatitis B Virus Infection in Shenzhen, China, 2015-2018
Jian Tao et al.
SCIENTIFIC REPORTS (2019)
The Path to Cancer and Back: Immune Modulation During Hepatitis C Virus Infection, Progression to Fibrosis and Cancer, and Unexpected Roles of New Antivirals
Jose D. Debes et al.
TRANSPLANTATION (2017)
Molecular and Transcriptional Basis of CD4+ T Cell Dysfunction during Chronic Infection
Alison Crawford et al.
IMMUNITY (2014)
A Population-Based Study Examining Hepatitis B Virus Infection and Immunization Rates in Northwest China
Zhaohua Ji et al.
PLOS ONE (2014)
Seroepidemiology of hepatitis B virus infection among adults in Singapore: A 12-year review
Li Wei Ang et al.
VACCINE (2013)
Hepatitis B virus infections and risk factors among the general population in Anhui Province, China: an epidemiological study
Xiaoqing Li et al.
BMC PUBLIC HEALTH (2012)
Share Paper
